Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 39

    1.

    Alexander disease.

    Zafeiriou DI, Dragoumi P, Vargiami E.

    J Pediatr. 2013 Mar;162(3):648. doi: 10.1016/j.jpeds.2012.09.047. Epub 2012 Nov 10. No abstract available.

    PMID:
    23149175
    [PubMed - indexed for MEDLINE]
    2.

    Recognizable phenotypes associated with intracranial calcification.

    Livingston JH, Stivaros S, van der Knaap MS, Crow YJ.

    Dev Med Child Neurol. 2013 Jan;55(1):46-57. doi: 10.1111/j.1469-8749.2012.04437.x. Epub 2012 Nov 1.

    PMID:
    23121296
    [PubMed - indexed for MEDLINE]
    3.

    Beneficial effects of αB-crystallin in spinal cord contusion injury.

    Klopstein A, Santos-Nogueira E, Francos-Quijorna I, Redensek A, David S, Navarro X, López-Vales R.

    J Neurosci. 2012 Oct 17;32(42):14478-88. doi: 10.1523/JNEUROSCI.0923-12.2012.

    PMID:
    23077034
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions.

    Renard D, Brochet B, Vukusic S, Edan G, Deburghgraeve V, Goizet C, Dupuy D, Touze E, Deschamps R, Zephyr H, Creange A, Castelnovo G, Boespflug-Tanguy O, Labauge P.

    Eur Neurol. 2012;68(3):156-61. Epub 2012 Aug 14.

    PMID:
    22907640
    [PubMed - indexed for MEDLINE]
    5.

    Alexander's disease: reassessment of a neonatal form.

    Singh N, Bixby C, Etienne D, Tubbs RS, Loukas M.

    Childs Nerv Syst. 2012 Dec;28(12):2029-31. doi: 10.1007/s00381-012-1868-8. Epub 2012 Aug 14. Review.

    PMID:
    22890470
    [PubMed - indexed for MEDLINE]
    6.

    Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease.

    LaPash Daniels CM, Austin EV, Rockney DE, Jacka EM, Hagemann TL, Johnson DA, Johnson JA, Messing A.

    J Neurosci. 2012 Aug 1;32(31):10507-15. doi: 10.1523/JNEUROSCI.1494-12.2012.

    PMID:
    22855800
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Beneficial effects of curcumin on GFAP filament organization and down-regulation of GFAP expression in an in vitro model of Alexander disease.

    Bachetti T, Di Zanni E, Balbi P, Ravazzolo R, Sechi G, Ceccherini I.

    Exp Cell Res. 2012 Sep 10;318(15):1844-54. doi: 10.1016/j.yexcr.2012.06.008. Epub 2012 Jun 15.

    PMID:
    22705585
    [PubMed - indexed for MEDLINE]
    8.

    Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival.

    Hagemann TL, Jobe EM, Messing A.

    PLoS One. 2012;7(5):e37304. doi: 10.1371/journal.pone.0037304. Epub 2012 May 31.

    PMID:
    22693571
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Alexander disease.

    Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE.

    J Neurosci. 2012 Apr 11;32(15):5017-23. doi: 10.1523/JNEUROSCI.5384-11.2012. No abstract available.

    PMID:
    22496548
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Splice site, frameshift, and chimeric GFAP mutations in Alexander disease.

    Flint D, Li R, Webster LS, Naidu S, Kolodny E, Percy A, van der Knaap M, Powers JM, Mantovani JF, Ekstein J, Goldman JE, Messing A, Brenner M.

    Hum Mutat. 2012 Jul;33(7):1141-8. doi: 10.1002/humu.22094. Epub 2012 Apr 30.

    PMID:
    22488673
    [PubMed - indexed for MEDLINE]
    11.

    Leukodystrophies.

    Perlman SJ, Mar S.

    Adv Exp Med Biol. 2012;724:154-71. doi: 10.1007/978-1-4614-0653-2_13. Review.

    PMID:
    22411242
    [PubMed - indexed for MEDLINE]
    12.

    Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.

    Yoshida T, Nakagawa M.

    Neuropathology. 2012 Aug;32(4):440-6. doi: 10.1111/j.1440-1789.2011.01268.x. Epub 2011 Nov 28. Review.

    PMID:
    22118268
    [PubMed - indexed for MEDLINE]
    13.

    Archetypal and new families with Alexander disease and novel mutations in GFAP.

    Messing A, Li R, Naidu S, Taylor JP, Silverman L, Flint D, van der Knaap MS, Brenner M.

    Arch Neurol. 2012 Feb;69(2):208-14. doi: 10.1001/archneurol.2011.1181. Epub 2011 Oct 10. Erratum in: Arch Neurol. 2012 May;69(5):643.

    PMID:
    21987397
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    An unusual presentation of juvenile Alexander disease.

    Osorio MJ, Risen S, Alper G.

    J Child Neurol. 2012 Apr;27(4):507-10. doi: 10.1177/0883073811419263. Epub 2011 Sep 21.

    PMID:
    21940697
    [PubMed - indexed for MEDLINE]
    15.

    GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

    Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, Fain D, Fernandez R, Ferreira J, Fleming J, Gill D, Griebel M, Heilstedt H, Kaplan P, Lewis D, Nakagawa M, Pedersen R, Reddy A, Sawaishi Y, Schneider M, Sherr E, Takiyama Y, Wakabayashi K, Gorospe JR, Vanderver A.

    Neurology. 2011 Sep 27;77(13):1287-94. doi: 10.1212/WNL.0b013e3182309f72. Epub 2011 Sep 14.

    PMID:
    21917775
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Neurocognitive decline in Alexander disease.

    Restrepo J, Bernardin L, Hammeke T.

    Clin Neuropsychol. 2011 Oct;25(7):1266-77. doi: 10.1080/13854046.2011.604043. Epub 2011 Sep 9.

    PMID:
    21902566
    [PubMed - indexed for MEDLINE]
    17.

    Late-onset Alexander disease with a V87L mutation in glial fibrillary acidic protein (GFAP) and calcifying lesions in the sub-cortex and cortex.

    Suzuki H, Yoshida T, Kitada M, Ichihashi J, Sasayama H, Nishikawa Y, Mistui Y, Nakagawa M, Kusunoki S.

    J Neurol. 2012 Mar;259(3):457-61. doi: 10.1007/s00415-011-6201-z. Epub 2011 Aug 7.

    PMID:
    21822933
    [PubMed - indexed for MEDLINE]
    18.

    Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

    Chen YS, Lim SC, Chen MH, Quinlan RA, Perng MD.

    Exp Cell Res. 2011 Oct 1;317(16):2252-66. doi: 10.1016/j.yexcr.2011.06.017. Epub 2011 Jul 2.

    PMID:
    21756903
    [PubMed - indexed for MEDLINE]
    19.

    Focal central white matter lesions in Alexander disease.

    Barreau P, Prust MJ, Crane J, Loewenstein J, Kadom N, Vanderver A.

    J Child Neurol. 2011 Nov;26(11):1422-4. doi: 10.1177/0883073811405381. Epub 2011 May 13.

    PMID:
    21572052
    [PubMed - indexed for MEDLINE]
    20.

    Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis.

    Yoshida T, Sasaki M, Yoshida M, Namekawa M, Okamoto Y, Tsujino S, Sasayama H, Mizuta I, Nakagawa M; Alexander Disease Study Group in Japan.

    J Neurol. 2011 Nov;258(11):1998-2008. doi: 10.1007/s00415-011-6056-3. Epub 2011 May 1.

    PMID:
    21533827
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk